Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Korro Bio absorbs Frequency Therapeutics in reverse biotech merger

Por: The Boston Globe Business July 15, 2023

thumbnail

Venture-backed Korro Bio of Cambridge said Friday it will absorb financially struggling Frequency Therapeutics through a reverse merger in which Korro will take over Frequency’s public stock listing by the end of the year.The deal will leave five-year-old Korro with $170 million in cash to advance its pipeline of six drug candidates. The company is pioneering a process called RNA editing, in which scientists modify the molecular messengers... + full article



Similar News

15 Biotech Stocks Wall Street Analysts Say Are Too Cheap

MarketWatch USA Business June 21, 2023

thumbnailThe XBI is still down roughly 50% from its high in February 2021, but things in the sector are looking better than they have in a while. In an effort to find opportunities, Barron’s screened the XBI and another biotech ETF, the (IBB), for the stocks with a market value of more... + más

US health system will go 'bankrupt' in 'a few years,' biotech entrepreneur warns | Fox Business

Daydream Believers: Read This Before You Invest In AI | Forbes


Biotechs face headwinds as the industry’s annual bash returns to Boston

The Boston Globe USA Business June 04, 2023

thumbnailThe world has changed since 2018 when the Biotechnology Innovation Organization last brought its annual road show to Boston, complete with entrepreneurial boot camps, beer-flowing receptions, and four days of nonstop networking.Since then, a global pandemic showcased the... + más

What Are the Duties of A Trustee? | Forbes

Many Biotechs Have Net Assets That Top Their Market Values | MarketWatch


US health system will go 'bankrupt' in 'a few years,' biotech entrepreneur warns

Fox Business USA Tech April 06, 2023

thumbnailGraviton Chairman and CEO Sam Waksal joined ‘Mornings with Maria’ to discuss the recent ‘implosion’ in the biotech sector and the country's latest efforts to fuel Alzheimer’s research. One biotech leader is sounding the alarm on a dire problem faced by the health... + más

Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe

'Frustration' fuels Broncos' sideline blowup in loss | ESPN


Daydream Believers: Read This Before You Invest In AI

Forbes USA Business March 04, 2023

thumbnailAI is going from red hot to white hot. Is that hot enough to burn investors? Pitchbook notes that venture capital investment in generative AI like ChatGPT is up 425% since 2020, from $500 million to more than $2.1 billion. The global VC industry is plunked into AI. Roughly 40%... + más

What 'Moonage Daydream' Teaches Us About David Bowie | Time

‘Moonage Daydream’ celebrates David Bowie and his many ch-ch-ch-ch-changes | The Boston Globe


‘Holding on by its fingernails.’ The biotech industry in Massachusetts braces for another tough year.

The Boston Globe USA Business January 21, 2023

thumbnailIt’s hard to overstate the Boston biotechnology industry’s astronomical growth, which has overflowed from its longtime stronghold of Kendall Square in Cambridge into the Fenway, Seaport, and surrounding suburbs. But by most financial measures, 2022 was a terrible, horrible,... + más

NFL Week 4: Across the league, teams have hit the ground running this year | The Boston Globe

Boston biotech internship program aims to increase diversity through expansion | The Boston Globe


Duke, MIT, and Stanford scientists create RNA technology that could improve genetic therapies

The Boston Globe USA Business November 06, 2022

thumbnailScientists from Duke, MIT, and Stanford have independently devised a molecular trick that could help make genetic therapies safer and more effective. The technology, which was disclosed in three separate papers published recently, could help ensure that treatments based on DNA... + más

Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’ | The Boston Globe

Sally Kornbluth named next MIT president | The Boston Globe


Boston startup Ascidian Therapeutics charts vision for therapies that ‘rewrite RNA’

The Boston Globe USA Business October 12, 2022

thumbnailCompetition is heating up among biotech startups building technologies that improve or expand upon what gene editing can do. While most of these firms are devising therapies that permanently modify DNA to treat, and potentially cure, genetic diseases, a growing number think that... + más

Tech insiders have a lot to say about the local startup scene. Most of it is good. | The Boston Globe

See the presentations that hot healthcare startups used to raise millions from top VCs | Business Insider



About iurex | Privacy Policy | Disclaimer |